EP3501605

TRANSLATE BIO, INC.
Application Number
EP18205194A
Filing Date
Oct 22, 2014
Status
Granted And Under Opposition
May 26, 2023
Grant Date
Jun 28, 2023
External Links
Slate, Register

Biblio Summary

The patent EP3501605B1 was granted on Jun 28, 2023 by Translate Bio, Inc. The patent is currently Granted And Under Opposition.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

AWA SWEDEN ABMar 28, 2024ADMISSIBLE

The table below shows the patents of Translate Bio, Inc. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2858679Pulmonary Delivery Of Mrna To Non-Lung Target CellsJun 5, 20241
EP2970456Methods And Compositions For Delivering Mrna Coded AntibodiesMay 19, 20214
EP3336082Cleavable LipidsApr 15, 20202